Cat: PAX2000-11480

Recombinant Human SLC7A2 Protein,GST

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    SLC7A2

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    ATRC2; 20.5; Amino acid transporter; cationic 2 (low affinity); ATRC 2; CAT 2; CAT-2; CAT2; Cat2a; Cat2b; Cationic amino acid transporter 2A; cationic amino acid transporter; y+ system; low affinity cationic amino acid transporter 2; CTR2_HUMAN; HCAT 2; HCAT2; Low affinity cationic amino acid transporter 2; OTTHUMP00000216432; OTTHUMP00000216433; OTTMUSP00000041667; OTTMUSP00000041669; RCAT2; SLC7A 2; Slc7a2; Solute carrier family 7 member 2; T cell early activation protein; Tea

  • Species

    Human

  • Source

    E. coli

  • Tag

    GST-tag at N-terminal

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P52569

  • Expression Region

    1-657 aa

  • AA Sequence

    MIPCRAALTFARCLIRRKIVTLDSLEDTKLCRCLSTMDLIALGVGSTLGAGVYVLAGEVAKADSGPSIVVSFLIAALASVMAGLCYAEFGARVPKTGSAYLYTYVTVGELWAFITGWNLILSYVIGTSSVARAWSGTFDELLSKQIGQFLRTYFRMNYTGLAEYPDFFAVCLILLLAGLLSFGVKESAWVNKVFTAVNILVLLFVMVAGFVKGNVANWKISEEFLKNISASAREPPSENGTSIYGAGGFMPYGFTGTLAGAATCFYAFVGFDCIATTGEEVRNPQKAIPIGIVTSLLVCFMAYFGVSAALTLMMPYYLLDEKSPLPVAFEYVGWGPAKYVVAAGSLCALSTSLLGSMFPLPRILFAMARDGLLFRFLARVSKRQSPVAATLTAGVISALMAFLFDLKALVDMMSIGTLMAYSLVAACVLILRYQPGLSYDQPKCSPEKDGLGSSPRVTSKSESQVTMLQRQGFSMRTLFCPSLLPTQQSASLVSFLVGFLAFLVLGLSVLTTYGVHAITRLEAWSLALLALFLVLFVAIVLTIWRQPQNQQKVAFMVPFLPFLPAFSILVNIYLMVQLSADTWVRFSIWMAIGFLIYFSYGIRHSLEGHLRDENNEEDAYPDNVHAAAEEKSAIQANDHHPRNLSSPFIFHEKTSEF

  • Molecular Weight

    98.1 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

SLC7A2, also known as the solute carrier family 7 member 2, encodes a protein that functions as an amino acid transporter, primarily responsible for the uptake of neutral amino acids in various tissues. This protein plays a critical role in regulating amino acid homeostasis, which is essential for numerous physiological processes, including protein synthesis, neurotransmission, and metabolism. Abnormalities in SLC7A2 expression and function have been linked to several health conditions, including mental disorders, obesity, and metabolic syndromes. The study of recombinant SLC7A2 protein is vital for elucidating its structure-function relationships and understanding the molecular mechanisms underlying its transport activity. Recombinant proteins allow for the investigation of SLC7A2's substrate specificity, transport kinetics, and interaction with inhibitors or activators, which can provide insights into potential therapeutic targets for diseases associated with its dysfunction. Furthermore, advancements in recombinant protein production techniques enhance the ability to generate large quantities of SLC7A2, facilitating both in vitro and in vivo studies. This research not only contributes to the basic understanding of amino acid transport but also holds promise for the development of novel pharmacological strategies aimed at modulating SLC7A2 activity to improve health outcomes in related disorders.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US